The Glp-1 Analog Liraglutide Protects Against Angiotensin II and Pressure Overload-Induced Cardiac Hypertrophy via PI3K/Akt1 and AMPKa Signaling

The Glp-1 Analog Liraglutide Protects Against Angiotensin II and Pressure Overload-Induced Cardiac Hypertrophy via PI3K/Akt1 and AMPKa Signaling

The Glp-1 analog, liraglutide (Lir), has been shown to reduce infarct size and improve cardiac function after myocardial ischemia in rodents with or without diabetes. However, the effect of Lir on angiotensin II (AngII) and pressure overload induced cardiac hypertrophy in nondiabetic mice and the un...

Full description

Bibliographic Details
Main Authors: Ran Li, Yingguang Shan, Lu Gao, Xi Wang, Xule Wang, Fang Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-06-01
Series:Frontiers in Pharmacology
Subjects:
liraglutide
cardiac hypertrophy
angiotensin II
AMPK a2
pressure overload
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00537/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2019.00537/full

Similar Items